Dolasetron USP Related Compound A with CAS No: 115956-07-5 is an impurity standard of Dolasetron. Dolasetron, a serotonin 5-HT3 receptor antagonist, is primarily employed as an antiemetic, playing a crucial role in preventing nausea and vomiting associated with chemotherapy, radiation therapy, and surgical procedures. Its effectiveness lies in its ability to competitively block serotonin at 5-HT3 receptors, particularly in the chemoreceptor trigger zone and the gastrointestinal tract. This makes dolasetron a valuable pharmaceutical asset in managing chemotherapy-induced nausea and vomiting (CINV) as well as postoperative nausea and vomiting (PONV). By mitigating the impact of serotonin release during these medical interventions, dolasetron significantly contributes to improving patient comfort and compliance during and after treatments. Buy high quality Dolasetron USP Related Compound A from Chemicea Pharmaceuticals. Chemicea Pharmaceuticals is one of the leading manufacturer and exporter of Dolasetron USP Related Compound A
Dolasetron USP Related Compound A
CAT. No.
CP-D39001
CAS. No.
115956-07-5
Mol. F.
C10H15NO2
Mol. Wt.
181.24
Stock Status
Custom Synthesis
Category:
Impurity Standards
Synonyms:
NA
Chemical Name:
(5s,6R,8r,9aS)-8-Hydroxyhexahydro-2H-2,6-methanoquinolizin-3(4H)-one
Request for Quotation : Dolasetron USP Related Compound A
Search by Keywords - Buy 115956-07-5 | Purchase 115956-07-5 | Order 115956-07-5 | Enquire 115956-07-5 | Price of 115956-07-5 | 115956-07-5 Cost | 115956-07-5 Supplier | 115956-07-5 Distributor | 115956-07-5 Manufacturer | 115956-07-5 Exporter | Dolasetron USP Related Compound A for Method Validation | Dolasetron USP Related Compound A for ANDA Filing | Dolasetron USP Related Compound A for Forced Degradation Studies | Dolasetron USP Related Compound A Identification Standards | Dolasetron USP Related Compound A for DMF Filing | Dolasetron
We have received your request successfully. Thank you for your interest in our product line. To
provide you with a Quotation, Our Sales team will contact you shortly.
Chemicea Pharmaceuticals Pvt. Ltd.
Thank You
You will receive blog content, featuring scientific research and exclusive promotions.